Meta’s Quest 2 Headset Price Hike Leaves Analyst Worried About The Gear Losing ‘Critical Competitive Advantage’
July 27, 7:27 AM
Meta Platforms, Inc. (NASDAQ: META) announced Tuesday that it increasing the price of its Quest 2 headset by $100, beginning August.
Bill Ackman Explains Why Inflation, Not Fed Rate Hike, Is Biggest Threat To US Economy
July 27, 5:33 AM
Billionaire hedge fund manager and CEO of Pershing Square Holdings Ltd. (OTC: PSHZF) Bill Ackman explained through a series of tweets that the biggest risk to the U.S.
Cathie Wood Dumps $75M Of Coinbase Stock At Massive Loss After Long Being Bullish
July 27, 4:42 AM
Cathie Wood-led Ark Investment Management on Tuesday liquidated a large chunk of Coinbase Global, Inc. (NASDAQ: COIN) shares amid a sell-off in the cryptocurrency exchange triggered by reports of an
Cathie Wood Shares How Bitcoin Miners Can Harness Harmful Methane Emissions
July 26, 11:12 PM
Ark Investment Management founder and Chief Investment Officer Cathie Wood shared new research that explains how Bitcoin (CRYPTO: BTC) can potentially transform methane emissions into Bitcoin mining that can "turbocharge" electricity generated
MasTec Price Target Cut By Analysts Post IEA Deal Announcement
July 26, 3:53 PM
Credit Suisse analyst Jamie Cook lowered the price target on MasTec, Inc. (NYSE:MTZ) to $102 (an upside of 44%) from $103 while…
Apple And Microsoft’s Strengths And Weaknesses Ahead Of Their Earnings – Analyst’s Take
July 26, 3:51 PM
Rosenblatt shares its concerns and convictions over two significant U.S. Big Tech stocks ahead of their earnings results.
Woman-Health Focused Stock Agile Therapeutics Is ‘Better Positioned,’ Analyst Says While Upgrading Stock
July 26, 3:47 PM
Maxim Group upgraded Agile Therapeutics Inc (NASDAQ:AGRX) to Buy from Hold with a price target of $1, saying it should be…
IEA Gets Analysts Downgrade As Competing Bids Are Less Likely
July 26, 3:41 PM
DA Davidson analyst Brent Thielman downgraded Infrastructure & Energy Alternatives Inc (NYSE:IEA) to Neutral from Buy and reduced the price target to…
Seagen’s Bladder Cancer Trial Data Meets Expectation, Analysts Say
July 26, 3:38 PM
Earlier today, Seagen Inc (NASDAQ:FBI) and Astellas Pharma Inc (OTC:ALPMF) announced topline results from the phase 1b/2 EV-103 trial (KEYNOTE-869) cohort K of Padcev…